{"id":5649,"date":"2020-03-06T09:26:51","date_gmt":"2020-03-06T08:26:51","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-utser-mangold-till-likviditetsgarant\/"},"modified":"2020-03-06T09:26:51","modified_gmt":"2020-03-06T08:26:51","slug":"stayble-utser-mangold-till-likviditetsgarant","status":"publish","type":"cision-feed","link":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-utser-mangold-till-likviditetsgarant\/","title":{"rendered":"Stayble utser Mangold till likviditetsgarant"},"content":{"rendered":"<p><span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:10pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\">Syftet med likviditetsgarantin \u00e4r att f\u00f6rb\u00e4ttra likviditeten i aktien och minska skillnaden mellan k\u00f6p- och s\u00e4ljkurs. Uppdraget p\u00e5b\u00f6rjas f\u00f6rsta dag f\u00f6r handel som \u00e4r den 9 mars 2020.<\/span><\/span><\/span><\/span><\/p>\n<p><span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:10pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\">Mangold kommer i sitt uppdrag som likviditetsgarant att s\u00e4kerst\u00e4lla m\u00f6jligheten att handla i Staybles aktie varje dag genom att kontinuerligt st\u00e4lla handelsposter p\u00e5 vardera k\u00f6p- och s\u00e4ljsida i orderboken. En likviditetsgaranti \u00e4mnar skapa en mer korrekt prisbild i ett bolags aktie, vilket i f\u00f6ljd ger en mer korrekt v\u00e4rdering av Bolaget och ger m\u00f6jlighet till en f\u00f6rb\u00e4ttrad handelsvolym i aktien.<\/span><\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stayble Therapeutics AB (\u201dStayble\u201d eller \u201dBolaget\u201d) har utsett Mangold Fondkommission till likviditetsgarant f\u00f6r bolagets aktie p\u00e5 Nasdaq First North Growth Market med f\u00f6rsta dag f\u00f6r handel den 9 mars 2020.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5649"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/cision-feed"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5649"}],"version-history":[{"count":0,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5649\/revisions"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}